JP2003522157A5 - - Google Patents

Download PDF

Info

Publication number
JP2003522157A5
JP2003522157A5 JP2001557585A JP2001557585A JP2003522157A5 JP 2003522157 A5 JP2003522157 A5 JP 2003522157A5 JP 2001557585 A JP2001557585 A JP 2001557585A JP 2001557585 A JP2001557585 A JP 2001557585A JP 2003522157 A5 JP2003522157 A5 JP 2003522157A5
Authority
JP
Japan
Prior art keywords
cell cycle
regulatory protein
cycle regulatory
cancer
tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001557585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003522157A (ja
JP4936626B2 (ja
Filing date
Publication date
Priority claimed from DE10006033A external-priority patent/DE10006033B4/de
Application filed filed Critical
Publication of JP2003522157A publication Critical patent/JP2003522157A/ja
Publication of JP2003522157A5 publication Critical patent/JP2003522157A5/ja
Application granted granted Critical
Publication of JP4936626B2 publication Critical patent/JP4936626B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001557585A 2000-02-10 2001-02-07 癌およびその前段階に対する個体の免疫 Expired - Lifetime JP4936626B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10006033.1 2000-02-10
DE10006033A DE10006033B4 (de) 2000-02-10 2000-02-10 Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen
PCT/DE2001/000470 WO2001058477A2 (de) 2000-02-10 2001-02-07 Immunisierung eines individuums gegen carcinome und ihre vorstufen

Publications (3)

Publication Number Publication Date
JP2003522157A JP2003522157A (ja) 2003-07-22
JP2003522157A5 true JP2003522157A5 (OSRAM) 2008-03-27
JP4936626B2 JP4936626B2 (ja) 2012-05-23

Family

ID=7630548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001557585A Expired - Lifetime JP4936626B2 (ja) 2000-02-10 2001-02-07 癌およびその前段階に対する個体の免疫

Country Status (9)

Country Link
US (3) US20030139334A1 (OSRAM)
EP (1) EP1253938B1 (OSRAM)
JP (1) JP4936626B2 (OSRAM)
AT (1) ATE360439T1 (OSRAM)
AU (1) AU2001239160A1 (OSRAM)
CA (1) CA2400007C (OSRAM)
DE (2) DE10006033B4 (OSRAM)
ES (1) ES2286108T3 (OSRAM)
WO (1) WO2001058477A2 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1685839T3 (da) 1997-12-22 2013-06-24 Euro Celtique Sa Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
PL1729730T3 (pl) 2004-03-30 2009-06-30 Euro Celtique Sa Odporna na zniszczenie postać dawkowania zawierająca adsorbent i środek przeciwdziałający
WO2014089124A1 (en) * 2012-12-03 2014-06-12 Cenexys, Inc. Immunogenic compositions for inducing an immune response for elimination of senescent cells
CN103293308B (zh) * 2013-05-24 2014-11-26 尉军 一种检测肿瘤标志物p16抗原表位氨基酸序列及应用
CN111434674B (zh) * 2018-12-25 2024-02-09 上海细胞治疗集团有限公司 多肽组合物及其在癌症免疫治疗中的用途
CN111848732B (zh) * 2019-04-30 2024-03-12 上海细胞治疗集团有限公司 多肽组合物及疫苗

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889169A (en) * 1991-05-16 1999-03-30 Cold Spring Harbor Laboratory Cell cycle regulatory protein p16 gene
AU7015396A (en) * 1995-09-07 1997-03-27 Health Research Incorporated Cyclin e variants and use thereof
US5723313A (en) * 1995-09-27 1998-03-03 St. Jude Children's Research Hospital ARF-p19, a novel regulator of the mammalian cell cycle
US5733920A (en) * 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
US6287569B1 (en) * 1997-04-10 2001-09-11 The Regents Of The University Of California Vaccines with enhanced intracellular processing
ES2265165T3 (es) * 1997-07-10 2007-02-01 Mannkind Corporation Dispositivo para inducir una respuesta ltc.
WO1999019357A2 (en) * 1997-10-15 1999-04-22 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
US6066651A (en) 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
EP1141353A2 (en) * 1998-12-17 2001-10-10 CropDesign N.V. Plant cell cycle genes and uses thereof

Similar Documents

Publication Publication Date Title
WO2006060314A3 (en) Generation of replication competent viruses for therapeutic use
JP2003503454A5 (OSRAM)
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
FI1897548T4 (fi) T-solujen säätely
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
SE9800836D0 (sv) New Compounds
JP2005532372A5 (OSRAM)
GT200400239A (es) Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente
JP2003520232A5 (OSRAM)
NO20031273L (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
WO2003084539A3 (en) New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
HUP0401534A2 (hu) Módosított humán IX. faktor
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
NO20053918L (no) Aminosyrer med affinitet for alfa-2-delta-proteinet.
CY1106056T1 (el) Παραγωγα 2-αμινο-2-αλκυλ-5-επτενοϊκου και επτυνοϊκου οξεος χρησιμα σαν αναστολεις συνθασης νιτρικου οξειδιου
AU2003246373A8 (en) Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
WO2003005880A3 (en) Replikin peptides and uses thereof
ATE485833T1 (de) Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern
WO2003039591A3 (de) Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
WO2006072348A3 (de) Alkinyl-substituierte thiophene
WO2006088962A3 (en) Replikin peptides and uses thereof
WO2005005632A3 (fr) PETITS ARN INTERFERENTS SPECIFIQUES DES SOUS-UNITES α, α' ET β DE LA PROTEINE KINASE CK2 ET LEURS APPLICATIONS
DK1423525T3 (da) Rekombinant MVA, der kan eksprimere HCV-strukturantigener
WO2004054497A3 (de) Verwendung einer trpm8 aktivierenden substanz zur tumorbehandlung